NCT05605912 is a NA clinical trial of Control in Incomplete Spinal Cord Injury, sponsored by Sint Maartenskliniek.

Who is sponsoring NCT05605912?

NCT05605912 is sponsored by Sint Maartenskliniek.

What drugs are being tested in NCT05605912?

Interventions in NCT05605912: Control, Myosuit.

What condition does NCT05605912 study?

NCT05605912 studies Incomplete Spinal Cord Injury.

Is NCT05605912 still recruiting?

NCT05605912 is currently completed. Last updated 6 February 2026.

Last reviewed 2026-02-06 · How we verify

NCT05605912

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myosuit in Incomplete Spinal Cord Injury

Completed NA Last updated 6 February 2026

What this trial tests

NA trial testing Control in Incomplete Spinal Cord Injury in 34 participants. Completed in 21 August 2025.

Timeline

3 October 2022

Primary endpoint
21 August 2025

21 August 2025

Quick facts

Lead sponsor	Sint Maartenskliniek
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	34
Start date	3 October 2022
Primary completion	21 August 2025
Estimated completion	21 August 2025
Sites	1 location across Netherlands

Drugs / interventions tested

Control
Myosuit

Conditions studied

Incomplete Spinal Cord Injury — all drugs for Incomplete Spinal Cord Injury →

Sponsor

Sint Maartenskliniek — full company profile →

Who can join

18 and older, any sex, with Incomplete Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Myosuit is a light-weighted lower extremity soft exosuit which provide assistance during walking. In this study the Myosuit will be tested in the home and community setting in patients with incomplete spinal cord injury.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of a soft exosuit on daily life gait performance in people with incomplete spinal cord injury: study protocol for a randomized controlled trial.
Visch L, Groen BE, Geurts ACH, van Nes IJW, et al · · 2024 · cited 1× · PMID 39242508 · DOI 10.1186/s13063-024-08412-2
Effect of an exosuit on gait capacity in individuals with incomplete spinal cord injury: A cross-sectional study.
Visch L, Groen BE, Geurts ACH, Van Nes IJW, et al · · 2026 · PMID 42047584 · DOI 10.1080/10790268.2026.2660441
Effect of an exosuit on daily life gait performance in individuals with incomplete spinal cord injury: a randomized controlled trial.
Visch L, Groen BE, Geurts ACH, van Nes IJW, et al · · 2026 · PMID 41826999 · DOI 10.1186/s12984-026-01941-8

Verify or expand the search:

Other trials of Control

Trials testing the same drug.

NCT06064604 — Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · NA · not yet recruiting
NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting

Other recruiting trials for Incomplete Spinal Cord Injury

Currently open trials in the same condition.

NCT07237386 — Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neuro · NA · recruiting
NCT07135583 — Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury · NA · recruiting
NCT05726591 — Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Dis · NA · recruiting
NCT05491837 — Effects of Intermittent Hypoxia in Upper and Lower Limb Functions in Persons With Incomplete Spinal Cord Injury · NA · recruiting
NCT04809987 — Effectiveness of Virtual Gait System Intervention in Motor Function in People with Incomplete Spinal Cord Injury. · NA · active not recruiting

Other Sint Maartenskliniek trials

Trials by the same sponsor.

NCT07160231 — REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases · Phase 4 · recruiting
NCT06578182 — The Effect of ColcHicine on the Incidence of Knee or Hip Replacements · Phase 3 · recruiting
NCT06259227 — Cardiorespiratory Fitness Training in Patients With Incomplete Spinal Cord Injury · NA · terminated
NCT06214546 — Effect of Different Support Systems on Gait · NA · completed
NCT06516120 — Kinematics of Movements Provoked by an Augmented Reality App · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05605912 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sint Maartenskliniek
Last refreshed: 6 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05605912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing